Mitochondrial genome deletions in the brain and their role in neurodegenerative diseases

References

• Anderson S., Bankier A.T., Barrell B.G., et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457–465
   PubMed Web of Science ®Google Scholar
• Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., Frishman W.H., Fisher D., Katzman R. Women, myocardial infarction, and dementia in the very old. Neurology 1990; 40: 1102–1106
   PubMed Web of Science ®Google Scholar
• Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., Wallace D.C. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genetics 1992; 1: 11–15
   PubMed Web of Science ®Google Scholar
• Beal M.F. Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases. R. G. Landes Co., Austin 1995
   Google Scholar
• Beck I., Weinmann R., Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 1993; 82: 704–711
   PubMed Web of Science ®Google Scholar
• Bernes S.M., Bacino C., Prezant T.R., et al. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. Journal of Pediatrics 1993; 123: 598–602
   PubMed Web of Science ®Google Scholar
• Blanchard B.J., Park T., Fripp W.J., Lerman L.S., Ingram V.M. A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue. Neuroreport 1993; 4: 799–802
   Google Scholar
• Chawluk J.B., Dann R., Alavi A., Hurtig H.I., Gur R.E., Resnick S., et al. The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. Nuclear Medicine and Biology 1990; 17: 797–804
   Google Scholar
• Cormier V., Rtig A., Tardieu M., Colonna M., Saudubray J.-M., Munnich A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. American Journal of Human Genetics 1991; 48: 643–648
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M., Horton T., Lott M.T., et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994; 23: 471–476
   PubMedGoogle Scholar
• Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., Beal M.F., Wallace D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genetics 1992; 2: 324–329
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M., Stepien G., Shoffner J.M., Lott M.T., Kanter K., Wallace D.C. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Journal of the American Medical Association 1991; 266: 1812–1816
   PubMed Web of Science ®Google Scholar
• Cortopassi G.A., Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Research 1990; 18: 6927–6933
   PubMed Web of Science ®Google Scholar
• Cote J., Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science 1993; 261: 765–769
   PubMed Web of Science ®Google Scholar
• Cumming A.M., Robertson F. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clinical Genetics 1984; 25: 310–318
   PubMed Web of Science ®Google Scholar
• Cummings D.J., Wright R.M. DNA sequence of the excision sites of a mitochondrial plasmid from senescent. Podospora anserina, Nucleic Acids Research 1983; 11: 2111–2119
   PubMedGoogle Scholar
• Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988; 8: 1–21
   Google Scholar
• DiMauro S., Bonilla E., Lombes A., Shanske S., Minetti C., Moraes C.T. Mitochondrial encephalomyopathies. Pediatric Neurology 1990; 8: 483–506
   Google Scholar
• Domena J.D., Mosbaugh D.W. Purification of nuclear and mitochondrial uracil-DNA glycosylase from rat liver. Identification of two distinct subcellular forms. Biochemistry 1985; 24: 7320–7328
   Google Scholar
• Drayer B.P., Burger P., Darwin R., Riederer S., Herfkens R., Johnson G.A. MRI of brain iron. American Journal of Radiology 1986; 147: 103–110
   Google Scholar
• Ernster L., Ikkos D., Luft R. Enzymatic activities of human skeletal muscle mitochondria: A tool in clinical metabolic research. Nature 1959; 184: 1851–1854
   PubMed Web of Science ®Google Scholar
• Evan G.I., Wyllie A.H., Gilbert C.S., et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119–128
   PubMed Web of Science ®Google Scholar
• Grant I., Heaton R.K., McSweeny A.J., Adams K.M., Timms R.M. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Archives of Interned Medicine 1982; 142: 1470–1476
   PubMed Web of Science ®Google Scholar
• Gupta K.P., Van Golen K.L., Randerath E., Randerath K. Age-dependent covalent DNA alterations (I-compounds) in rat liver mitochondrial DNA. Mutation Research 1990; 237: 17–27
   Google Scholar
• Halliwell B., Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends in Neuroscience 1985; 8: 22–26
   Web of Science ®Google Scholar
• Hallman D.M., Boerwinkle E., Saha N., Sandhozer C., Menzel H.J., Caázár A., Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. American Journal of Human Genetics 1991; 49: 338–349
   PubMed Web of Science ®Google Scholar
• Hardy J.A., Wester P., Winblad B., Gezeltus C., Bring G., Eriksson A. The patients dying after long terminal phase have acidotic brains, implications for biochemical measurements on autopsy tissue. Journal of Neural Transmission 1985; 61: 253–264
   PubMed Web of Science ®Google Scholar
• Hattori K., Tanaka M., Sugiyama S., Obayashi T., Takayki I., Satake T., et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. American Heart Journal 1991; 121: 1735–1742
   PubMedGoogle Scholar
• Hayashi J.-I., Ohta S., Kikuchi A., Takemitsu M., Goto Y.-I., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proceedings of the National Academy of Sciences, USA 1991; 88: 10614–10618
   PubMed Web of Science ®Google Scholar
• Heddi A., Lestienne P., Wallace D.C., Stepien G. Steady state levels of mitochondrial and nuclear oxidative phosphorylation transcripts in Kearns-Sayre syndrome. Biochimica et Biophysica Acta 1994; 1226: 206–212
   Google Scholar
• Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717–719
   PubMed Web of Science ®Google Scholar
• Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in mitochondrial myopathies: sequence analysis and possible mechanisms. Nucleic Acids Research 1989; 17: 4465–4469
   PubMed Web of Science ®Google Scholar
• Hutchin T., Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1995; 92: 6892–6895
   PubMedGoogle Scholar
• Ikeee S.-I., Tanaka M., Ohno K., Sata W., Hattori K., Kondo T., et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochemical and Biophysical Research Communications 1990; 170: 1044–1048
   Google Scholar
• Johns D.R., Rutledge S.L., Stine O.C., Hurko O. Directly repeated sequences associated with pathogenic mitochondrial DNA deletions. Proceedings of the National Academy of Sciences, USA 1989; 86: 8059–8062
   PubMedGoogle Scholar
• Katsumata K., Hayakawa M., Tanaka M., Sugiyama S., Ozawa T. Fragmentation of human heart mitochondrial DNA associated with premature aging. Biochemical and Biophysical Research Communications 1994; 202: 102–110
   Google Scholar
• Kearns T.P., Sayre G.P. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block. Archives of Ophthalmology 1958; 60: 280–289
   PubMed Web of Science ®Google Scholar
• Kearns T.P. External ophthalmoplegia, pigmentary degeneration of the retina, and cardiomyopathy: A newly recognized syndrome. Transactions of the American Ophthalmological Society 1965; 63: 559–625
   PubMedGoogle Scholar
• Kuppuswamy M.N., Hoffman J.W., Kasper C.K., et al. Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proceedings of the National Academy of Sciences, USA 1991; 88: 1143–1147
   PubMed Web of Science ®Google Scholar
• Kuusi T., Nieminen M.S., Ehnholm C., Yki-Jarvtnen H., Valle M., Nikkila E.A., Taskinen M.-R. Apoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Atherosclerosis 1988; 9: 237–241
   Google Scholar
• Leveille A.S., Newell F.W. Autosomal dominant Kearns-Sayre syndrome. Ophthalmology 1980; 86: 99–108
   Google Scholar
• Levin C.J., Zimmerman S.B. A DNA ligase form mitochondria of rat liver. Biochemical and Biophysical Research Communications 1976; 69: 514–520
   PubMedGoogle Scholar
• Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. Journal of Biological Chemistry 1995; 270: 13333–13340
   PubMed Web of Science ®Google Scholar
• Lin F.-H., Lin R. A comparison of single nucleotide primer extension with mispairing PCR-RFLP in detecting a point mutation. Biochemical and Biophysical Research Communications 1992; 189: 1202–1206
   Google Scholar
• Lin F.-H., Lin R., Wisniewski H.M., et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochemical and Biophysical Research Communications 1992; 182: 238–246
   PubMed Web of Science ®Google Scholar
• Luft R., Ikkos D., Palmieri G., Ernster L., Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical, and morphological study. Journal of Clinical Investigation 1962; 41: 1776–1804
   PubMed Web of Science ®Google Scholar
• Mayer V.W., Legator M.S. Induction by N-methyi-N'-nitro-N-nitrosoguanidine and UV light of petite mutants in aerobically and anaerobically cultivated Saccharomyces cerevisiae. Mutation Research 1970; 9: 193–198
   Google Scholar
• Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Annals of Neurology 1994; 36: 747–751
   PubMed Web of Science ®Google Scholar
• Menzies R.A., Gold P.H. The turnover of mitochondria in a variety of tissues of young adult and aged rats. Journal of Biological Chemistry 1971; 246: 2425–2459
   PubMed Web of Science ®Google Scholar
• Merril C.R., Zullo S., Ghanbari H. Is there a relationship between conditions associated with chronic hypoxia, the mitochondria, and neurodegenerative diseases, such as Alzheimer's disease?. 1995, In press
   Google Scholar
• Mita S., Rizzuto R., Moraes C.T., Shanske S., Arnauddo E., Fabrizi G.M., et al. Recombination via flanking direct repeats is a major cause of large scale deletions of human mitochondrial DNA. Nucleic Acids Research 1990; 18: 561–567
   PubMed Web of Science ®Google Scholar
• Moraes C.T., DiMauro S., Zeviani M., Lombes A., Shanske S., Miranda A., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. New England Journal of Medicine 1989; 320: 1293–1299
   PubMed Web of Science ®Google Scholar
• Nakase H., Moraes C.T., Rizzuto R., Lombes A., DiMauro S., Schon E.A. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: Implications for pathogenesis. American Journal of Human Genetics 1990; 46: 418–427
   PubMed Web of Science ®Google Scholar
• Ozawa T., Tanaka M., Ikebe S.-I., Ohno K., Kondo T., Mizuno Y. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochemical and Biophysical Research Communications 1990; 172: 483–489
   PubMed Web of Science ®Google Scholar
• Ozawa T. Mechanisms of somatic mitochondrial DNA mutations associated with age and diseases. Biochimica et Biophysica Acta 1995; 1271: 177–189
   PubMed Web of Science ®Google Scholar
• Petruzzella V., Chen X., Schon E.A. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease?. Biochemical and Biophysical Research Communications 1992; 186: 491–497
   Google Scholar
• Pinz K.G., Shibutani S., Bogenhagen D.F. Action of mitochondrial DNA polymerase gamma at sites of base loss or oxidative damage. Journal of Biological Chemistry 1995; 270: 9202–9206
   PubMed Web of Science ®Google Scholar
• Poulton J., Deadman M.E., Bindoff L., Morten K., Land J., Brown G. Families of mtDNA rearrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Human Molecular Genetics 1993; 2: 23–30
   PubMed Web of Science ®Google Scholar
• Prigatano G.P., Parsons O., Wright E., Levin D.C., Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. Journal of Consulting Clinical Psychology 1983; 51: 108–116
   PubMed Web of Science ®Google Scholar
• Pulsinelli W. The ischemic penumbra in stroke. Scientific American Science and Medicine 1995; 2: 16–25
   Google Scholar
• Reichmann H., Flrke S., Hebenstreit G., Schrubar H., Riederer P. Analysis of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. Journal of Neurology 1993; 240: 377–380
   Google Scholar
• Richter C., Park J.-W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proceedings of the National Academy of Sciences, USA 1988; 85: 6465–6467
   PubMed Web of Science ®Google Scholar
• Rosenbaum D.M., Michaelson M., Batter D.K., Doshi P., Kessler J.A. Evidence for hypoxia-induced, programmed cell death of cultured neurons. Annals of Neurology 1994; 36: 864–870
   PubMed Web of Science ®Google Scholar
• Schon E.A., Rizzuto R., Moraes C.T., Nakase H., Zeviani M., Dimauro S. A direct repeat is a hotspot for large scale deletion of human mitochondrial DNA. Science 1989; 244: 346–349
   PubMed Web of Science ®Google Scholar
• Schurr A., Rigor B.M. The mechanism of neuronal resistance and adaptation to hypoxia. FEBS Letters 1987; 224: 4–8
   PubMedGoogle Scholar
• Seibel P., Degoul F., Romero N., Marsac C., Kadenbach B. Identification of point mutations by mispairing PCR as exemplified in MERRF disease. Biochemical and Biophysical Research Communications 1990; 173: 561–565
   Google Scholar
• Shapiro T.A. Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation. Molecular and Cellular Biology 1994; 14: 3660–3667
   PubMedGoogle Scholar
• Shoffner J.M., Wallace D.C. Oxidative phosphorylation diseases. Disorders of two genomes. Advances in Human Genetics 1990; 19: 267–330
   PubMed Web of Science ®Google Scholar
• Shoffner J.M., Brown M.D., Torroni A., Lott M.T., et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17: 171–184
   PubMed Web of Science ®Google Scholar
• Shoffner J.M., Lott M.T., Voliavec A.S., Soueidan S.A., Costigan D.A., Wallace D.C. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proceedings of the National Academy of Sciences, USA 1989; 86: 7952–7956
   PubMed Web of Science ®Google Scholar
• Shoubridge E.A., Karpati G., Hastings K.E.M. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 1990; 62: 43–49
   PubMedGoogle Scholar
• Somjen G.G. Effects of hypoxia on neuronal membranes. Cellular Membrane: a key to disease processes, S.T. Ohnishi, T. Ohnishi. CRC Press, Boca Raton 1993; 181–207
   Google Scholar
• Soong N.-W., Hinton D.R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genetics 1992; 2: 318–323
   PubMed Web of Science ®Google Scholar
• Sparks D.L., Liu H., Scheff S.W., Coyne C.M., Hunsaker J.C. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. Journal of Neuropathology and Experimental Neurology 1993; 52: 135–142
   PubMed Web of Science ®Google Scholar
• Sparks D.L., Scheff S.W., Hunsaker J.C., Liu H., Landers T., Gross D.R. Induction of Alzheimer-like -amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Experimental Neurology 1994; 126: 88–94
   PubMed Web of Science ®Google Scholar
• Strittmatter W.J., Saunders A.M., Schmechel D.E., Pericak-Vance M., Enchild I., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proceedings of the National Academy of Sciences, USA 1993; 90: 1977–1981
   PubMed Web of Science ®Google Scholar
• Suzuki C.K., Suda K., Wang N., Schatz G. Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. Science 1994; 264–273; 276–891
   Google Scholar
• Terada L.S., Guidot D.M., Leff J.A., et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proceedings of the National Academy of Sciences, USA 1992; 89: 3362–3366
   PubMed Web of Science ®Google Scholar
• Tomkinson A.E., Bonk R.T., Linn S. Mitochondrial endonuclease activities specific for apurinic/apyrimidinic sites in DNA from mouse cells. Journal of Biological Chemistry 1988; 25: 12532–12537
   Google Scholar
• Tuder R.M., Floor B.E., Voelkel N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Journal of Clinical Investigations 1995; 95: 1798–1807
   PubMed Web of Science ®Google Scholar
• Veltri K.L., Espiritu M., Singh G. Distinct genomic copy number in mitochondria of different mammalian organs. Journal of Cellular Physiology 1990; 143: 160–164
   PubMed Web of Science ®Google Scholar
• Wallace D.C. Maternal genes: Mitochondrial diseases. Medical and Experimental Mammalian Genetics. A Perspective, V.A. McKusick, T.H. Roderick, J. Mori, N.W. Paul. Birth Defects Original Article Series, 1987; 23: 137–190
   Google Scholar
• Wallace D.C., Ye J., Neckelmann S.N., Singh G., Webster K.A., Greenberg B.D. Sequence analysis of cDNA's for the human and bovine ATP Synthase β subunit: mitochondrial DNA genes sustain seventeen times more mutations. Current Genetics 1987; 12: 81–90
   PubMed Web of Science ®Google Scholar
• Wallace D.C. Diseases of the mitochondrial DNA. Annual Review of Biochemistry 1992; 61: 1175–1212
   PubMed Web of Science ®Google Scholar
• Wallace D.C. Mitochondrial diseases: genotype versus phenotype. Trends in Genetics 1993; 5: 9–13
   Google Scholar
• Wallace D.C., Shoffner J., Trounce M.I., et al. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochimica et Biophysica Acta 1995; 1271: 141–151
   PubMed Web of Science ®Google Scholar
• Wang G.L., Jiang B.-H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences, USA 1995; 92: 5510–5514
   PubMed Web of Science ®Google Scholar
• Wang N., Gottesman S., Willingham M.C., Gottesman M.M., Maurizi M.R. A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon protease. Proceedings of the National Academy of Sciences, USA 1993; 90: 11247–11251
   PubMedGoogle Scholar
• Yuzaki M., Ohkoshi N., Kanazawa I., Kagawa Y., Ohta S. Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy. Biochemical and Biophysical Research Communications 1989; 164: 1352–1357
   PubMedGoogle Scholar
• Zeviani M., Bonilla E., DeVivo D.C., DiMauro S. Mitochondrial diseases. Neurology Clinics 1989a; 7: 123–156
   Google Scholar
• Zeviani M., Bresolin N., Gellera C., et al. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. American Journal of Human Genetics 1990; 47: 904–914
   PubMedGoogle Scholar
• Zeviani M., Moraes C.T., DiMauro S., Nakase H., Bonilla E., Schon E.A., Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38: 1339–1346
   PubMed Web of Science ®Google Scholar
• Zeviani M., Servidei S., Gellera C., Bertini E., DiMauro S., DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989b; 339: 309–311
   PubMed Web of Science ®Google Scholar
• Zupanc M.L., Moraes C.T., Shanske S., Langman C.B., Ciafaloni E., DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Annals of Neurology 1991; 29: 680–683
   PubMed Web of Science ®Google Scholar